Krystal Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	496.3	344.87	358.33	161.9	341.25
Short-Term Investments	331.49	252.65	173.85	217.27	96.85
Cash & Short-Term Investments	827.79	597.52	532.18	379.17	438.1
Cash Growth	38.54%	12.28%	40.35%	-13.45%	61.50%
Accounts Receivable	127.43	104.75	42.04	-	-
Inventory	40.48	26.51	6.99	-	-
Other Current Assets	28.91	13.27	6.71	4.61	4.17
Total Current Assets	1,025	742.05	587.91	383.78	442.27
Net Property, Plant & Equipment	158.02	161.45	168.23	169.73	119.58
Long-Term Investments	128.07	152.11	61.95	4.62	64.37
Other Long-Term Assets	23.11	0.23	0.26	0.32	0.07
Total Assets	1,334	1,056	818.36	558.45	626.3
Accounts Payable	3.24	4.99	4.13	3.98	8.4
Accrued Expenses	97.93	95.79	27.49	23.31	16.3
Current Portion of Leases	1.77	1.22	1.47	1.56	1.04
Total Current Liabilities	102.94	102	33.09	28.85	25.74
Long-Term Leases	7.57	6.04	6.62	7.37	6.98
Other Long-Term Liabilities	3.72	1.42	-	-	-
Total Long-Term Liabilities	11.29	7.46	6.62	7.37	6.98
Total Liabilities	114.23	109.46	39.71	36.22	32.72
Additional Paid-in Capital	1,194	1,127	1,048	803.72	734.52
Accumulated Other Comprehensive Income	1.14	-0.19	0.64	-0.73	-0.16
Retained Earnings	24.16	-180.67	-269.83	-280.76	-140.78
Shareholders' Equity	1,220	946.38	778.64	522.23	593.58
Total Liabilities & Equity	1,334	1,056	818.36	558.45	626.3
Total Debt	9.34	7.26	8.09	8.93	8.02
Net Cash (Debt)	818.45	590.26	524.08	370.24	430.07
Net Cash Growth	38.66%	12.63%	41.55%	-13.91%	65.59%
Net Cash Per Share	27.33	19.85	18.89	14.52	19.38
Book Value	1,220	946.38	778.64	522.23	593.58
Book Value Per Share	40.72	31.82	28.06	20.49	26.74
Tangible Book Value	1,220	946.38	778.64	522.23	593.58
Tangible Book Value Per Share	40.72	31.82	28.06	20.49	26.74

Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q